Misplaced Pages

#23976

15-719: The Joseph Zubin Memorial Fund Award was granted by the Joseph Zubin Memorial Fund at the Research Foundation for Mental Hygiene at the New York State Psychiatric Institute . It was established by Zubin's colleagues and family to "recognize investigators who are in an early stage of their career, but have already made significant contributions to research in any area of psychopathology ." The award

30-427: A Congressional inquiry on an unrelated matter. In 1987 a federal judge ordered the government to pay US$ 700,000 in compensation to Blauer's surviving daughter. Notes Bibliography Harold Blauer Harold Blauer (1910 – January 8, 1953) was an American tennis player who died as a result of injections of 450 mg 3,4-methylenedioxyamphetamine (code-named EA-1298) as part of Project MKUltra ,

45-490: A covert CIA mind-control and chemical interrogation research program run by the Office of Scientific Intelligence . Blauer lost in the round before the quarterfinals of the 1935 United States Professional Tennis Tournament 3–6, 3–6, 3–6 to tennis legend (and eventual tournament champion) Bill Tilden . Blauer checked into the New York State Psychiatric Institute (NYSPI) in late 1952, seeking help for depression following

60-486: A divorce. While at the facility, he was used as a test subject in experiments conducted by the Army Chemical Corps . The Army had a classified agreement with the psychiatric institute that allowed them to study possible chemical warfare compounds by administering the substances to patients. Between November 1952 and January 1953, Blauer was given injections of various chemical analogues of mescaline . He

75-955: Is Dr. Joshua A. Gordon, MD, PhD. The institute was established in 1895 by the New York State Hospital Commission as the Pathological Institute of the New York State Hospitals. In 1907, its name changed to Psychiatric Institute of the State Hospitals. The 1927 Mental Hygiene Law designated it as the New York State Psychiatric Institute. In December 1929, the institute opened as a unit of the Columbia-Presbyterian Medical Center , owned and operated by

90-838: The Wayback Machine New York State Psychiatric Institute The New York State Psychiatric Institute , located at the Columbia University Irving Medical Center in the Washington Heights neighborhood of Manhattan , New York City , was established in 1895 as one of the first institutions in the United States to integrate teaching, research and therapeutic approaches to the care of patients with mental illnesses. In 1925,

105-681: The state of New York under the supervision of the Department of Mental Hygiene . It is also known by the following names: The institute has two buildings: the Herbert Pardes Building at 1051 Riverside Drive was built in 1998 and was designed by Peter Pran and Timothy Johnson of Ellerbe Becket . It is connected by walkway bridges to the high-rise Lawrence G. Kolb Research Laboratory at 40 Haven Avenue at West 168th Street , built in 1983 and designed by Herbert W. Reimer. Their original building at 722 West 168th Street became

120-691: The Institute affiliated with Presbyterian Hospital , now NewYork-Presbyterian Hospital , adding general hospital facilities to the institute's psychiatric services and research laboratories. Through the years, distinguished figures in American psychiatry have served as directors of the Psychiatric Institute, including Drs. Ira Van Gieson , Adolph Meyer , August Hoch , Otto Kernberg , Lawrence Kolb , Edward Sachar , Herbert Pardes and Jeffrey Lieberman . The current executive director

135-475: The Mailman's School of Public Health in 1999. In 1953, Harold Blauer , a patient undergoing treatment for depression at the institute, died following an injection of the amphetamine MDA given without his permission as part of a U.S. Army experiment. The United States and New York state governments and the Psychiatric Institute attempted to cover up the incident, a fact accidentally discovered in 1975 during

150-471: The mouth; after going into a coma, Blauer was pronounced dead at 12:15pm. NYSPI has claimed that the overdose was accidental since the safe doses for these mescaline analogues were based only on a guess. Following Blauer's death, animal tests were performed in 1953 to find out the LD50 values for the mescaline analogues ( MDMA and many other compounds) before some of them were tested on people. "If you look at

165-399: The same day as Blauer, another NYSPI patient was injected with MDA. She was given 150 mg instead of the planned 450 mg dose of MDA, because her reaction to MDA was "so violent that the injection was stopped when it was only one-third complete." The extent of Blauer's knowledge of the experiment is unclear, and after his death the experiment was covered up by the state of New York ,

SECTION 10

#1732775337024

180-693: The timing of when that research seems to be done, they were like, 'Oh crap, we just killed someone. We need to quickly do some animal toxicology studies'," observed neuroscientist Matthew Baggott. This was done, on behalf of the Army Chemical Warfare Corps, in secrecy at the University of Michigan . Dr Maurice H. Seevers , Director of the Department of Pharmacology at Michigan University in Ann Arbor, supervised these tests. On

195-656: Was co-sponsored by the University of Pittsburgh Medical Center Western Psychiatric Institute and Clinic, the University of Pittsburgh School of Medicine and the VA Pittsburgh Healthcare System . The award included an honorarium and was presented until 2010. Recipients : The Joseph Zubin Award is a lifetime achievement award given by the Society for Research in Psychopathology . It

210-685: Was established in 1986 and officially named the Joseph Zubin Award in 1990. Recipients : Source: Society for Research in Psychopathology The Joseph Zubin Award was established by the American Psychopathological Association in 1992 and is granted to psychologists who have "made seminal contributions to psychopathology research." Recipients: Source: APPA Previous Award Winners Archived 2019-08-03 at

225-474: Was first given relatively low doses of MDA ( 3,4-methylenedioxyamphetamine ), then DMA ( 3,4‐dimethoxyamphetamine ), MDPEA (3,4‐methylenedioxyphenethylamine) and DMA once again. Blauer requested to withdraw from these treatments because he got strong hallucinations from the injections. Despite this, on December 30, 1952 at 9:53 a.m., he was injected with a fatal dose of 450 milligrams (mg) of MDA. The injection caused sweating, tremors, flailing, and frothing at

#23976